EnsoData has partnered with Parachute Health, an ePrescribing platform for digital durable medical equipment (DME) orders, to connect sleep disorder diagnosis to therapy prescription, which will improve access for patients and physicians, the company announced recently.

According to a release, the collaboration will create a seamless handoff from a physician-signed sleep report directly through to DME suppliers using Parachute Health to ensure patients receive access to therapy and help improve sleep health more quickly.

“We’re excited to partner with Parachute Health to better serve patients, sleep physicians, and DME providers working from a footprint spanning thousands of physicians and major DMEs,” EnsoData President and CEO Justin Mortara said in a statement. “By partnering together, we’re setting ourselves up to support a high volume of patients immediately, with the ability to truly expand the overall impact we can have on patient lives and sleep medicine.”

More than 220,000 clinicians use the Parachute platform.

A DME consists of equipment and supplies ordered by a healthcare provider for everyday or extended use.